Barry Declan T, Beitel Mark, Cutter Christopher J, Fiellin David A, Madden Lynn M, Lipkind Nathan, Bollampally Pooja, Liong Christopher, Schottenfeld Richard S
Yale School of Medicine, 333 Cedar Street New Haven, CT 06510, USA; Yale Child Study Center, 230 South Frontage Road New Haven, CT 06519, USA; APT Foundation Pain Treatment Services, 495 Congress Avenue New Haven, CT 06519, USA.
Yale School of Medicine, 333 Cedar Street New Haven, CT 06510, USA; Yale Child Study Center, 230 South Frontage Road New Haven, CT 06519, USA; APT Foundation Pain Treatment Services, 495 Congress Avenue New Haven, CT 06519, USA.
Drug Alcohol Depend. 2021 Apr 1;221:108608. doi: 10.1016/j.drugalcdep.2021.108608. Epub 2021 Feb 15.
The study objective was to compare psychiatric comorbidity among patients seeking treatment for chronic pain and opioid use disorder (OUD) by order of condition onset (i.e., "Pain First," "OUD First," "Same Time").
Data from 170 patients entering two clinical trials of treatments for current comorbid chronic pain and OUD conducted between March 2009 and July 2013 were compared by order of condition onset. The Structured Clinical Interview for DSM-IV-TR Axis I Disorders and the Diagnostic Interview for DSM-IV Personality Disorders (Axis II) were performed by doctoral-level providers using a standardized training protocol. Age of onset group differences on specific diagnostic variables were examined using multinomial logistic regression.
Fifty-two percent were in the "Pain First" group (n = 89), 35 % in the "OUD First" group (n = 59), and 13 % in the "Same Time" group (n = 22). Compared with the Pain First group, the Same Time group was less likely to report heroin (vs. prescription opioids) as the primary drug used (OR = 0.20, 95 % CI = 0.06-0.72) or meet criteria for an Axis II disorder (OR = 0.24, 95 % CI = 0.07-0.83). Compared with the Pain First group, the OUD First group was more likely to meet criteria for a current nonopioid substance use disorder (OR = 3.20, 95 % CI = 1.22-8.40).
Our findings regarding differences in psychiatric comorbidity associated with order of condition onset indicate that varying pathways may exist for the emergence of chronic pain and OUD; further research should investigate potential treatment implications.
本研究的目的是按疾病发作顺序(即“疼痛在先”、“阿片类物质使用障碍在先”、“同时出现”)比较寻求慢性疼痛和阿片类物质使用障碍(OUD)治疗的患者的精神共病情况。
对2009年3月至2013年7月期间参加两项慢性疼痛和OUD共病当前治疗临床试验的170名患者的数据,按疾病发作顺序进行比较。由博士水平的提供者使用标准化培训方案进行《精神疾病诊断与统计手册》第四版修订本(DSM-IV-TR)轴I障碍的结构化临床访谈和《精神疾病诊断与统计手册》第四版人格障碍诊断访谈(轴II)。使用多项逻辑回归检查特定诊断变量在发病年龄组上的差异。
52%的患者属于“疼痛在先”组(n = 89),35%属于“阿片类物质使用障碍在先”组(n = 59),13%属于“同时出现”组(n = 22)。与“疼痛在先”组相比,“同时出现”组报告海洛因(与处方阿片类药物相比)作为主要使用药物的可能性较小(比值比[OR]=0.20,95%置信区间[CI]=0.06 - 0.72)或符合轴II障碍标准的可能性较小(OR = 0.24,95% CI = 0.07 - 0.83)。与“疼痛在先”组相比,“阿片类物质使用障碍在先”组更有可能符合当前非阿片类物质使用障碍标准(OR = 3.20,95% CI = 1.22 - 8.40)。
我们关于与疾病发作顺序相关的精神共病差异的研究结果表明,慢性疼痛和OUD的出现可能存在不同途径;进一步的研究应调查潜在的治疗意义。